MET and myeloid sarcoma: We next analyzed in MS patients the expression of Itgα4 on CD4+c‐Met− and CD4+c‐Met+ T cells by flow cytometry and we found an increase expression of Itgα4 on CD4+c‐Met+ T cells, compared to their c-Met− counterparts (Fig. 6C).